Skip to main content
Erschienen in: Journal of Neurology 8/2015

01.08.2015 | Original Communication

Progression of subcortical atrophy and iron deposition in multiple system atrophy: a comparison between clinical subtypes

verfasst von: Jae-Hyeok Lee, Tae-Hyung Kim, Chi-Woong Mun, Tae-Hyoung Kim, Yong-Hee Han

Erschienen in: Journal of Neurology | Ausgabe 8/2015

Einloggen, um Zugang zu erhalten

Abstract

Magnetic resonance imaging (MRI) can be useful not only for the diagnosis of multiple system atrophy (MSA) itself, but also to distinguish between different clinical subtypes. This study aimed to investigate whether there are differences in the progression of subcortical atrophy and iron deposition between two variants of MSA. Two serial MRIs at baseline and follow-up were analyzed in eight patients with the parkinsonian variant MSA (MSA-P), nine patients with cerebellar variant MSA (MSA-C), and fifteen patients with Parkinson’s disease (PD). The R2* values and volumes were calculated for the selected subcortical structures (caudate nucleus, putamen, globus pallidus, and thalamus) using an automated region-based analysis. In both volume and R2*, a higher rate of progression was identified in MSA-P patients. Volumetric analysis showed significantly more rapid progression of putamen and caudate nucleus in MSA-P than in MSA-C. With regard to R2* changes, a significant increase at follow-up and a higher rate of progression were identified in the putamen of MSA-P group compared to MSA-C and PD groups. This longitudinal study revealed different progression rates of MRI markers between MSA-P and MSA-C. Iron-related degeneration in the putamen may be more specific for MSA-P.
Literatur
1.
Zurück zum Zitat Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670–676PubMedCentralCrossRefPubMed Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670–676PubMedCentralCrossRefPubMed
2.
Zurück zum Zitat Ozawa T, Paviour D, Quinn NP, Josephs KA, Sangha H, Kilford L et al (2004) The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 127:2657–2671CrossRefPubMed Ozawa T, Paviour D, Quinn NP, Josephs KA, Sangha H, Kilford L et al (2004) The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 127:2657–2671CrossRefPubMed
3.
Zurück zum Zitat Sitburana O, Ondo WG (2009) Brain magnetic resonance imaging (MRI) in parkinsonian disorders. Parkinsonism Relat Disord 15:165–174CrossRefPubMed Sitburana O, Ondo WG (2009) Brain magnetic resonance imaging (MRI) in parkinsonian disorders. Parkinsonism Relat Disord 15:165–174CrossRefPubMed
4.
Zurück zum Zitat Horimoto Y, Aiba I, Yasuda T, Ohkawa Y, Katayama T, Yokokawa Y et al (2002) Longitudinal MRI study of multiple system atrophy—when do the findings appear, and what is the course? J Neurol 249:847–854CrossRefPubMed Horimoto Y, Aiba I, Yasuda T, Ohkawa Y, Katayama T, Yokokawa Y et al (2002) Longitudinal MRI study of multiple system atrophy—when do the findings appear, and what is the course? J Neurol 249:847–854CrossRefPubMed
5.
Zurück zum Zitat Lee EA, Cho HI, Kim SS, Lee WY (2004) Comparison of magnetic resonance imaging in subtypes of multiple system atrophy. Parkinsonism Relat Disord 10:363–368CrossRefPubMed Lee EA, Cho HI, Kim SS, Lee WY (2004) Comparison of magnetic resonance imaging in subtypes of multiple system atrophy. Parkinsonism Relat Disord 10:363–368CrossRefPubMed
6.
Zurück zum Zitat Minnerop M, Specht K, Ruhlmann J, Schimke N, Abele M, Weyer A et al (2007) Voxel-based morphometry and voxel-based relaxometry in multiple system atrophy-a comparison between clinical subtypes and correlations with clinical parameters. Neuroimage 36:1086–1095CrossRefPubMed Minnerop M, Specht K, Ruhlmann J, Schimke N, Abele M, Weyer A et al (2007) Voxel-based morphometry and voxel-based relaxometry in multiple system atrophy-a comparison between clinical subtypes and correlations with clinical parameters. Neuroimage 36:1086–1095CrossRefPubMed
7.
Zurück zum Zitat Pellecchia MT, Barone P, Mollica C, Salvatore E, Ianniciello M, Longo K et al (2009) Diffusion-weighted imaging in multiple system atrophy: a comparison between clinical subtypes. Mov Disord 24:689–696CrossRefPubMed Pellecchia MT, Barone P, Mollica C, Salvatore E, Ianniciello M, Longo K et al (2009) Diffusion-weighted imaging in multiple system atrophy: a comparison between clinical subtypes. Mov Disord 24:689–696CrossRefPubMed
8.
Zurück zum Zitat Wang PS, Wu HM, Lin CP, Soong BW (2011) Use of diffusion tensor imaging to identify similarities and differences between cerebellar and Parkinsonism forms of multiple system atrophy. Neuroradiology 53:471–481CrossRefPubMed Wang PS, Wu HM, Lin CP, Soong BW (2011) Use of diffusion tensor imaging to identify similarities and differences between cerebellar and Parkinsonism forms of multiple system atrophy. Neuroradiology 53:471–481CrossRefPubMed
9.
Zurück zum Zitat Ji L, Zhu D, Xiao C, Shi J (2014) Tract based spatial statistics in multiple system atrophy: a comparison between clinical subtypes. Parkinsonism Relat Disord 20:1050–1055CrossRefPubMed Ji L, Zhu D, Xiao C, Shi J (2014) Tract based spatial statistics in multiple system atrophy: a comparison between clinical subtypes. Parkinsonism Relat Disord 20:1050–1055CrossRefPubMed
10.
Zurück zum Zitat Nicoletti G, Rizzo G, Barbagallo G, Tonon C, Condino F, Manners D et al (2013) Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease. Radiology 267:843–850CrossRefPubMed Nicoletti G, Rizzo G, Barbagallo G, Tonon C, Condino F, Manners D et al (2013) Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease. Radiology 267:843–850CrossRefPubMed
11.
Zurück zum Zitat Lee JH, Han YH, Kang BM, Mun CW, Lee SJ, Baik SK (2013) Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and parkinsonian variant of multiple system atrophy. J Neurol 260:2094–2101CrossRefPubMed Lee JH, Han YH, Kang BM, Mun CW, Lee SJ, Baik SK (2013) Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and parkinsonian variant of multiple system atrophy. J Neurol 260:2094–2101CrossRefPubMed
12.
Zurück zum Zitat Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease. A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCentralCrossRefPubMed Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease. A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCentralCrossRefPubMed
13.
Zurück zum Zitat Draganski B, Ashburner J, Hutton C, Kherif F, Frackowiak RS, Helms G et al (2011) Regional specificity of MRI contrast parameter changes in normal ageing revealed by voxelbased quantification (VBQ). Neuroimage 55:1423–1434PubMedCentralCrossRefPubMed Draganski B, Ashburner J, Hutton C, Kherif F, Frackowiak RS, Helms G et al (2011) Regional specificity of MRI contrast parameter changes in normal ageing revealed by voxelbased quantification (VBQ). Neuroimage 55:1423–1434PubMedCentralCrossRefPubMed
14.
Zurück zum Zitat Seppi K, Schocke MF, Mair KJ, Esterhammer R, Scherfler C, Geser F et al (2006) Progression of putaminal degeneration in multiple system atrophy: a serial diffusion MR study. Neuroimage 31:240–245CrossRefPubMed Seppi K, Schocke MF, Mair KJ, Esterhammer R, Scherfler C, Geser F et al (2006) Progression of putaminal degeneration in multiple system atrophy: a serial diffusion MR study. Neuroimage 31:240–245CrossRefPubMed
15.
Zurück zum Zitat Pellecchia MT, Barone P, Vicidomini C, Mollica C, Salvatore E, Ianniciello M et al (2011) Progression of striatal and extrastriatal degeneration in multiple system atrophy: a longitudinal diffusion-weighted MR study. Mov Disord 26:1303–1309CrossRefPubMed Pellecchia MT, Barone P, Vicidomini C, Mollica C, Salvatore E, Ianniciello M et al (2011) Progression of striatal and extrastriatal degeneration in multiple system atrophy: a longitudinal diffusion-weighted MR study. Mov Disord 26:1303–1309CrossRefPubMed
16.
Zurück zum Zitat Bunzeck N, Singh-Curry V, Eckart C, Weiskopf N, Perry RJ, Bain PG et al (2013) Motor phenotype and magnetic resonance measures of basal ganglia iron levels in Parkinson’s disease. Parkinsonism Relat Disord 19:1136–1142PubMedCentralCrossRefPubMed Bunzeck N, Singh-Curry V, Eckart C, Weiskopf N, Perry RJ, Bain PG et al (2013) Motor phenotype and magnetic resonance measures of basal ganglia iron levels in Parkinson’s disease. Parkinsonism Relat Disord 19:1136–1142PubMedCentralCrossRefPubMed
17.
Zurück zum Zitat Matsusue E, Fujii S, Kanasaki Y, Sugihara S, Miyata H, Ohama E et al (2008) Putaminal lesion in multiple system atrophy: postmortem MR-pathological correlations. Neuroradiology 50:559–567CrossRefPubMed Matsusue E, Fujii S, Kanasaki Y, Sugihara S, Miyata H, Ohama E et al (2008) Putaminal lesion in multiple system atrophy: postmortem MR-pathological correlations. Neuroradiology 50:559–567CrossRefPubMed
18.
Zurück zum Zitat Köllensperger M, Wenning GK (2009) Assessing disease progression with MRI in atypical parkinsonian disorders. Mov Disord 24(Suppl 2):S699–S702CrossRefPubMed Köllensperger M, Wenning GK (2009) Assessing disease progression with MRI in atypical parkinsonian disorders. Mov Disord 24(Suppl 2):S699–S702CrossRefPubMed
19.
Zurück zum Zitat Hauser TK, Luft A, Skalej M, Nägele T, Kircher TT, Leube DT et al (2006) Visualization and quantification of disease progression in multiple system atrophy. Mov Disord 21:1674–1681CrossRefPubMed Hauser TK, Luft A, Skalej M, Nägele T, Kircher TT, Leube DT et al (2006) Visualization and quantification of disease progression in multiple system atrophy. Mov Disord 21:1674–1681CrossRefPubMed
20.
Zurück zum Zitat Crivello F, Tzourio-Mazoyer N, Tzourio C, Mazoyer B (2014) Longitudinal assessment of global and regional rate of grey matter atrophy in 1172 healthy older adults: modulation by sex and age. PLoS One 9:e114478PubMedCentralCrossRefPubMed Crivello F, Tzourio-Mazoyer N, Tzourio C, Mazoyer B (2014) Longitudinal assessment of global and regional rate of grey matter atrophy in 1172 healthy older adults: modulation by sex and age. PLoS One 9:e114478PubMedCentralCrossRefPubMed
21.
Zurück zum Zitat Watanabe H, Saito Y, Terao S, Ando T, Kachi T, Mukai E et al (2002) Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain 125:1070–1083CrossRefPubMed Watanabe H, Saito Y, Terao S, Ando T, Kachi T, Mukai E et al (2002) Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain 125:1070–1083CrossRefPubMed
Metadaten
Titel
Progression of subcortical atrophy and iron deposition in multiple system atrophy: a comparison between clinical subtypes
verfasst von
Jae-Hyeok Lee
Tae-Hyung Kim
Chi-Woong Mun
Tae-Hyoung Kim
Yong-Hee Han
Publikationsdatum
01.08.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 8/2015
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-015-7785-5

Weitere Artikel der Ausgabe 8/2015

Journal of Neurology 8/2015 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.